Sumathi Nambiar, MD MPH

Senior Director
Johnson and Johnson
Germantown, Maryland, United States

Disclosure(s): Johnson and Johnson: Stocks/Bonds (Public Company)

Presentation(s):

• 84 - Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin-Structure Infections

  Thursday, October 17, 2024
  11:00 AM – 11:15 AM US PT